Allegion PLC

1. 1

   Annual Election of Directors

   ManagementBoard: FOR

   Elect eight director nominees named in the proxy statement to serve one-year terms until the 2027 AGM.

2. 2

   Advisory Vote to Approve Executive Compensation

   ManagementBoard: FOR

   Non-binding advisory vote to approve the compensation of the company's named executive officers as disclosed in the proxy statement.

   More detail

   The proposal asks shareholders to provide a non-binding advisory approval of the compensation of the Company’s named executive officers (NEOs) as disclosed in the Proxy Statement, including the CD&A and compensation tables. Management seeks this advisory endorsement to demonstrate shareholder support for its pay-for-performance program, which includes a mix of base salary, annual cash incentives (AIP), and long-term equity incentives (PSUs, options, RSUs) tied to adjusted EPS, relative TSR and other metrics; these programs are overseen by the Compensation and Human Capital Committee and guided by an independent compensation consultant. The Board recommends a vote FOR, citing alignment of pay with Company performance and governance practices such as clawback policies, share ownership requirements, and capped incentive payouts. Notable context includes strong 2025 financial performance, elevated AIP and PSU payouts (131.31% AIP financial score, PSU payout of 125% for the 2023–2025 period), and the Committee’s responsiveness to shareholder feedback (94% support in 2025). Though advisory and non-binding, the Committee will consider results when making future compensation decisions; potential investor concerns could center on pay magnitude, use of discretion in adjustments, or performance metric selection, but the disclosed program emphasizes alignment and risk mitigants.

3. 3

   Advisory Vote on the Frequency of Say-on-Pay

   ManagementBoard: FOR

   Non-binding advisory vote for shareholders to indicate whether the advisory say-on-pay vote should occur every one, two, or three years (Board recommends one year).

   More detail

   The proposal requests that shareholders express a preference for how frequently the non-binding advisory vote on executive compensation should occur: every one, two, or three years, or abstain. The Board recommends an annual vote (one year) to ensure frequent shareholder input; it cites previous strong shareholder support for annual votes. This advisory vote is not binding but will guide the Compensation and Human Capital Committee’s practice. Annual frequency promotes accountability and timely feedback on compensation policies, while some investors argue for less frequent votes to reduce administrative burden. Given the company’s prior 98.4% support in 2020 for annual frequency and ongoing engagement, management recommends a vote for one year.

4. 4

   Ratification of Appointment of Independent Registered Public Accounting Firm and Authorization to Set Remuneration

   ManagementBoard: FOR

   Ratify the appointment of PricewaterhouseCoopers (PwC) as the Company’s independent registered public accounting firm for fiscal 2026 and authorize the Audit and Finance Committee to set PwC’s remuneration.

5. 5

   Renew the Board’s Authority to Issue Shares under Irish Law

   ManagementBoard: FOR

   Authorize the Board to allot relevant securities up to approximately 20% of issued ordinary share capital under Irish law for 18 months or until the next AGM.

   More detail

   This management proposal seeks shareholder approval to renew the Board’s authority under Irish law to allot ordinary shares representing up to roughly 20% of the company’s issued share capital for an 18-month period. Management presents this as routine corporate housekeeping necessary to preserve capital-raising flexibility, support equity compensation plan issuances, and facilitate M&A financing when needed. The Board recommends FOR, emphasizing that the authority aligns with Irish market practice and NYSE/SEC protections remain in place. The proposal contains typical safeguards, including an expiry date and allowance for pre-agreements made before expiry.

6. 6

   Authorize the Board to Opt Out of Statutory Preemptive Rights under Irish Law (Special Resolution

   ManagementBoard: FOR

   Special resolution to empower the Board to allot equity securities for cash without first offering to existing shareholders (statutory pre-emption rights) up to ~20% of issued share capital for 18 months, with exceptions for rights issues.

   More detail

   This special-resolution seeks shareholder approval to disapply statutory pre-emption rights under Irish law for issuances of ordinary shares for cash up to approximately 20% of issued share capital (except in proportionate rights issues), for 18 months. Management frames it as standard practice for Irish PLCS and necessary to facilitate equity compensation plan functioning and corporate finance activities, while noting NYSE and SEC protections. The Board recommends FOR; approval requires a 75% affirmative vote as a special resolution under Irish law.

Upcoming shareholder meetings at Allegion PLC’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Allegion PLC 2026 annual meeting?

Allegion PLC (ALLE) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.

What is the record date for the Allegion PLC 2026 meeting?

The record date for the Allegion PLC 2026 meeting is Thursday, April 9, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Allegion PLC's 2026 meeting?

The board is presenting 8 director nominees at the Allegion PLC 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Allegion PLC 2026 meeting?

Shareholders will vote on 6 proposals at the Allegion PLC 2026 meeting, each tagged with who proposed it and the board's recommendation.